MedTrace Logo

A Grapefruit Feeding Trial in Healthy, Overweight Adults

NCT01452841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2011-10-17

No results posted yet for this study

Summary

Folklore has suggested that consuming grapefruit may promote weight control. Sparse data exist to support this hypothesis, though there is some evidence of health promotional effects regarding blood pressure and lipid profiles. The aims of this randomized controlled trial are to determine the role of grapefruit in:

1. Reducing weight
2. Reducing blood pressure
3. Reducing inflammation
4. Improving the lipid profile.

The investigators hypothesize that six weeks of daily consumption of grapefruit will reduce weight, blood pressure, and inflammation while improving the lipid profile in overweight, healthy adults.

Conditions

Interventions

OTHER

Grapefruit

1.5 Rio Red Grapefruit consumed daily for 6 weeks

OTHER

Control

Participants followed a diet low in bioactive rich fruits and vegetables and avoided citrus for six weeks

Sponsors & Collaborators

Principal Investigators

  • Cynthia Thomson, PhD, RD · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01452841 on ClinicalTrials.gov